Domagoj Markovic1, Gorana Trgo2, Ingrid Prkacin3, Damir Fabijanic4, Vedran Kovacic2. 1. Clinic for Heart and Cardiovascular Diseases, University Hospital Split, Spinciceva 1, 21 000, Split, Croatia. markovic.domagoj@gmail.com. 2. Clinic for Internal Medicine, University Hospital Split, Spinciceva 1, 21 000, Split, Croatia. 3. Clinic for Internal Medicine, Clinical Hospital "Merkur", Zajceva 19, 10 000, Zagreb, Croatia. 4. Clinic for Heart and Cardiovascular Diseases, University Hospital Split, Spinciceva 1, 21 000, Split, Croatia.
Abstract
PURPOSE: Several studies investigated the association between the estimated glomerular filtration rate (eGFR) and the concentration of high-density lipoproteins (HDL) in patients without severely damaged kidney function. As results of those studies were inconclusive and contradictory, we wanted to investigate this association in multiple cardiovascular disease (CVD) risk patients without severe kidney disease or renal failure. METHODS: We enrolled a cohort of 187 patients with intermediate and high CVD risk without severe renal disease. We grouped them based on their eGFR into: group 1 (≥ 30 < 60 ml/min/1.73 m2), group 2 (≥ 60 < 90 ml/min/1.73 m2) and group 3 (≥ 90 ml/min/1.73 m2). We analyzed the difference between their HDL levels and assessed the association of HDL and eGFR in three regression models with the following predictors: model 1 (age and gender), model 2 (model 1 plus smoking status, hs-CRP and diabetes mellitus) and model 3 (model 2 plus excessive weight and obesity, hypertension, hypercholesterolemia, hypertriglyceridemia, family history of CVD and medications they used). RESULTS: Patients with the lowest eGFR had the lowest HDL values (P = 0.013). In multiple linear regression, HDL was an independent predictor of eGFR (β = 0.189, P = 0.025) which was also shown in multinomial regression for all three models: model 1 [odds ratio (OR) 0.05; 95% confidence interval (CI) 0.007-0.331; P = 0.002], model 2 (OR 0.052; 95% CI 0.006-0.428; P = 0.006) and model 3 (OR 0.2; 95% CI 0.001-0.309; P = 0.005). CONCLUSIONS: Low HDL is an independent predictor of lower eGFR in intermediate and high CVD risk patients without severe kidney disease. In such patients, low HDL could be one of the early indicators of renal failure.
PURPOSE: Several studies investigated the association between the estimated glomerular filtration rate (eGFR) and the concentration of high-density lipoproteins (HDL) in patients without severely damaged kidney function. As results of those studies were inconclusive and contradictory, we wanted to investigate this association in multiple cardiovascular disease (CVD) risk patients without severe kidney disease or renal failure. METHODS: We enrolled a cohort of 187 patients with intermediate and high CVD risk without severe renal disease. We grouped them based on their eGFR into: group 1 (≥ 30 < 60 ml/min/1.73 m2), group 2 (≥ 60 < 90 ml/min/1.73 m2) and group 3 (≥ 90 ml/min/1.73 m2). We analyzed the difference between their HDL levels and assessed the association of HDL and eGFR in three regression models with the following predictors: model 1 (age and gender), model 2 (model 1 plus smoking status, hs-CRP and diabetes mellitus) and model 3 (model 2 plus excessive weight and obesity, hypertension, hypercholesterolemia, hypertriglyceridemia, family history of CVD and medications they used). RESULTS:Patients with the lowest eGFR had the lowest HDL values (P = 0.013). In multiple linear regression, HDL was an independent predictor of eGFR (β = 0.189, P = 0.025) which was also shown in multinomial regression for all three models: model 1 [odds ratio (OR) 0.05; 95% confidence interval (CI) 0.007-0.331; P = 0.002], model 2 (OR 0.052; 95% CI 0.006-0.428; P = 0.006) and model 3 (OR 0.2; 95% CI 0.001-0.309; P = 0.005). CONCLUSIONS: Low HDL is an independent predictor of lower eGFR in intermediate and high CVD risk patients without severe kidney disease. In such patients, low HDL could be one of the early indicators of renal failure.
Authors: Suguru Yamamoto; Patricia G Yancey; T Alp Ikizler; W Gray Jerome; Ryohei Kaseda; Brian Cox; Aihua Bian; Ayumi Shintani; Agnes B Fogo; Macrae F Linton; Sergio Fazio; Valentina Kon Journal: J Am Coll Cardiol Date: 2012-11-07 Impact factor: 24.094
Authors: R Kozyraki; J Fyfe; M Kristiansen; C Gerdes; C Jacobsen; S Cui; E I Christensen; M Aminoff; A de la Chapelle; R Krahe; P J Verroust; S K Moestrup Journal: Nat Med Date: 1999-06 Impact factor: 53.440
Authors: Markus Ketteler; Geoffrey A Block; Pieter Evenepoel; Masafumi Fukagawa; Charles A Herzog; Linda McCann; Sharon M Moe; Rukshana Shroff; Marcello A Tonelli; Nigel D Toussaint; Marc G Vervloet; Mary B Leonard Journal: Kidney Int Date: 2017-07 Impact factor: 10.612
Authors: Michael P Quinn; Christopher R Cardwell; Frank Kee; Alexander P Maxwell; Gerard Savage; Peter McCarron; Damian G Fogarty Journal: Nephrol Dial Transplant Date: 2010-08-16 Impact factor: 5.992
Authors: Anoop Shankar; Chenlei Leng; Kee Seng Chia; David Koh; E Shyong Tai; Seang Mei Saw; Su Chi Lim; Tien Yin Wong Journal: Nephrol Dial Transplant Date: 2007-12-21 Impact factor: 5.992
Authors: Michelle C Odden; Ira B Tager; Ron T Gansevoort; Stephan J L Bakker; Linda F Fried; Anne B Newman; Ronit Katz; Suzanne Satterfield; Tamara B Harris; Mark J Sarnak; David Siscovick; Michael G Shlipak Journal: Ann Epidemiol Date: 2013-01-10 Impact factor: 3.797